Hindustan Bio Sciences Ltd — Board Meeting, 30-05-2026: Board Meeting
30-05-2026 | 06:50 pm
30-05-2026 | 06:50 pm
Hindustan Biosciences board approved Q4 results, posting a loss of ₹0.12 Cr. For FY26, revenue was ₹0.74 Cr, with a net loss of ₹0.08 Cr. Mr. GBK Viswanadham was appointed Internal Auditor. Equity capital stands at ₹2.05 Cr.
No comments yet. Be the first to comment!
